Technical Analyst, Ashwani Gujral is of the view that Ranbaxy Laboratories is doing very well. So, people can go long on that on all declines.
Gujral told CNBC-TV18, "In pharma, Ranbaxy is doing very well. So, people can go long on that on all declines. Lupin is doing very well; Dr Reddys Laboratories is doing quite well. These are the two or three stocks that are showing strength even in weak markets."
